FDA Inspection 1106722 — Ivan Spicka MD, Ph.D
The FDA completed an inspection of Ivan Spicka MD, Ph.D on September 27, 2019 in Prague 28. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prague 28 (Czech Republic)
Additional Details
Clinical Investigator (CI)